Evaluation of an in silico predicted specific and immunogenic antigen from the OmcB protein for the serodiagnosis of Chlamydia trachomatis infections

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Frikha Gargouri, Olfa ^a   Gdoura, Radhouane ^a   Znazen, Abir ^a   Gargouri, Boutheina ^a   Gargouri, Jalel ^b   Rebai, Ahmed ^c   Hammami, Adnene ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b Department of Blood Bank ^*  (Tunisia)

^c CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DIAGNOSTIC AGENT; OMCB PROTEIN, BACTERIA; OUTER MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BIOLOGY; BLOOD; CHEMISTRY; CHILD; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; PHYSIOLOGY; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEROLOGY; STANDARD; WESTERN BLOTTING;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEROLOGIC TESTS;

EID: 58149308157     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-217     Document Type: Article

References (65)

1. Abortion in woman caused by caprine Chlamydophila abortus (Chlamydia psittaci serovar 1). A Pospischil R Thoma M Hilbe P Grest JO Gebbers, Swiss Med Wkly 2002 132 64 66 11971199
2. An unusual cause of sepsis during pregnancy: recognizing infection with Chlamydophila abortus. G Walder H Hotzel C Brezinka W Gritsch R Tauber R Würzner F Ploner, Obstet Gynecol 2005 106 1215 1217 16260577
3. Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). SF Dowell RW Peeling J Boman GM Carlone BS Fields J Guarner MR Hammerschlag LA Jackson CC Kuo M Maass TO Messmer DF Talkington ML Tondella SR Zaki C. pneumoniae Workshop Participants, Clin Infect Dis 2001 33 492 503 11462186
4. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. B Boyadzhyan T Yashina JH Yatabe M Patnaik CS Hill, J Clin Microbiol 2004 42 3089 3093 15243065
5. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. CA Gaydos M Theodore N Dalesio BJ Wood TC Quinn, J Clin Microbiol 2004 42 3041 3045 15243057
6. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. CM Black, Clin Microbiol Rev 1997 10 160 184 8993862
7. The use of serologic tests for the diagnosis of chlamydial infections. T Tuuminen P Palomaki J Paavonen, J Microbiol Methods 2000 42 265 279 11044570
8. Chlamydia pneumoniae and atherosclerosis - an update. P Saikku, Scand J Infect Dis Suppl 1997 104 53 56 9259083
9. Seroprevalence of Chlamydia trachomatis infection amongst patients with pelvic inflammatory diseases and infertility. S Vidhani S Mehta P Bhalla R Bhalla VK Sharma S Batra, J Commun Dis 2005 37 233 238 17080708
10. The potential role of serology in diagnosing chronic lymphogranuloma venereum (LGV): a case of LGV mimicking Crohn's disease. B Forrester J Pawade P Horner, Sex Transm Infect 2006 82 139 140 16581740
11. Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections. G Ozanne J Lefebvre, Can J Microbiol 1992 38 1185 1189 1477792
12. The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae. YK Wong JM Sueur CH Fall J Orfila ME Ward, J Clin Pathol 1999 52 99 102 10396235
13. Usefulness of enzyme linked immunosorbent assays species specific in the detection of Chlamydia trachomatis and Chlamydophila pneumoniae IgG antibodies in patients with genital infections or respiratory tract infections. O Frikha-Gargouri A Znazen R Gdoura B Gargouri NB Arab MB Jemaa Adnane Hammami, Pathol Biol 2008 56 143 147 18178034
14. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis. JM Ossewaarde JW Manten HJ Hooft AC Hekker, J Immunol Methods 1989 123 293 298 2681425
15. Chlamydia trachomatis species specific serology: ImmunoComb Chlamydia bivalent versus microimmunofluorescence (MIF). A Clad H Freidank J Plunnecke B Jung EE Petersen, Infection 1994 22 165 173 7927811
16. Sulfur-rich proteins of Chlamydia trachomatis : developmentally regulated transcription of polycistronic mRNA from tandem promoters. PR Lambden JS Everson ME Ward IN Clarke, Gene 1990 87 105 112 2332164
17. Serological response to Chlamydia pneumoniae infection. LA Campbell CC Kuo SP Wang JT Grayston, J Clin Microbiol 1990 28 1261 1264 2380354
18. Analysis of the human serological response to proteins of Chlamydia trachomatis. WJ Newhall B Batteiger RB Jones, Infect Immun 1982 38 1181 1189 6185424
19. Limits of the microimmunofluorescence test and advantages of immunoblotting in the diagnosis of chlamydiosis. M Biendo F Eb JF Lefebvre J Orfila, Clin Diagn Lab Immunol 1996 3 706 709 8914762
20. Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. M Sanchez-Campillo L Bini M Comanducci R Raggiaschi B Marzocchi V Pallini G Ratti, Electrophoresis 1999 20 2269 2279 10493131
21. Mapping of Chlamydia trachomatis proteins by immobiline-polyacrylamide two-dimensional electrophoresis: spot identification by N-terminal sequencing and immunoblotting. L Bini M Sanchez-Campillo A Santucci B Magi B Marzocchi M Comanducci G Christiansen S Birkelund R Cevenini E Vretou G Ratti V Pallini, Electrophoresis 1996 17 185 190 8907538
22. Chlamydia trachomatis from individuals in a sexually transmitted disease core group exhibit frequent sequence variation in the major outer membrane protein (omp1) gene. R Brunham C Yang I Maclean J Kimani G Maitha F Plummer, J Clin Invest 1994 94 458 463 8040290
23. Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. HD Caldwell PJ Hitchcock, Infect Immun 1984 44 306 314 6425219
24. Antigenic determinants of the chlamydial major outer membrane protein resolved at a single amino acid level. G Zhong RC Brunham, Infect Immun 1991 59 1141 1147 1705241
25. High resolution mapping of serovar specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. RS Stephens EA Wagar GK Schoolnik, J Exp Med 1988 167 817 31 2450954
26. Identification by sequence analysis of two-site posttranslational processing of the cysteine-rich outer membrane protein 2 of Chlamydia trachomatis serovar L2. JE Allen RS Stephens, J Bacteriol 1989 171 285 291 2914847
27. Architecture of the cell envelope of Chlamydia psittaci 6BC. KD Everett TP Hatch, J Bacteriol 1995 177 877 882 7532170
28. Topological analysis of Chlamydia trachomatis L2 outer membrane protein 2. P Mygind G Christiansen S Birkelund, J Bacteriol 1998 180 5784 5787 9791135
29. Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein. M Klein A Kotz K Bernardo M Kronke, J Clin Microbiol 2003 41 1957 1962 12734234
30. Chlamydia trachomatis OmcB protein is a surface-exposed glycosaminoglycan-dependent adhesin. S Fadel A Eley, J Med Microbiol 2007 56 15 22 17172511
31. Immunoreactivity of the 60 kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coli. MW Watson PR Lambden JS Everson IN Clarke, Microbiology 1994 140 2003 2011 7522846
32. Chlamydia trachomatis serology: diagnostic value of outer membrane protein 2 compared with that of other antigens. S Bas P Muzzin TL Vischer, J Clin Microbiol 2001 39 4082 4085 11682533
33. Analysis of the humoral immune response to Chlamydia outer membrane protein 2. P Mygind G Christiansen K Persson S Birkelund, Clin Diagn Lab Immunol 1998 5 313 318 9605983
34. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. JD Thompson DG Higgins TJ Gibson, Nucleic Acids Res 1994 22 4673 4680 7984417
35. EMBOSS: the European Molecular Biology Open Software Suite. P Rice I Longden A Bleasby, Trends Genet 2000 16 276 7 10827456
36. A semi-empirical method for prediction of antigenic determinants on protein antigens. AS Kolaskar PC Tongaonkar, FEBS Lett 1990 276 172 174 1702393
37. Reference points for comparisons of two-dimensional maps of proteins from different human cell types defined in a pH scale where isoelectric points correlate with polypeptide compositions. B Bjellqvist B Basse E Olsen JE Celis, Electrophoresis 1994 15 529 539 8055880
38. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. MM Bradford, Anal Biochem 1976 72 248 254 942051
39. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. UK Laemmli, Nature 1970 227 680 685 5432063
40. Human serology in Chlamydia trachomatis infection with microimmunofluorescence. SP Wang JT Grayston, J Infect Dis 1974 130 388 397 4613759
41. Characterization of intertype specific epitopes on adenoviruses hexon. T Zhang R Xin Q Zhang Y Bao J Wu, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2002 16 44 47 11986745
42. Bioinformatics analysis of mouse adiponectin receptor-1 and its antibody preparation. YW Xu L Yan H Liu Y Wu BW Wu, Sheng Li Xue Bao 2008 60 156 160 18288372
43. Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection. CS Jones PA Maple NJ Andrews ID Paul EO Caul, J Clin Pathol 2003 56 225 229 12610104
44. Novel enzyme immunoassay utilizing lipopolysaccharide-binding protein as a capture molecule for the measurement of chlamydial lipopolysaccharide in serum. T Tiirola A Jaakkola A Bloigu M Paldanius J Sinisalo MS Nieminen S Silvennoinen-Kassinen P Saikku M Jauhiainen M Leinonen, Diagn Microbiol Infect Dis 2006 54 7 12 16290027
45. Synthetic peptides as diagnostic tools in virology. P Leinikki M Lehtinen H Hyoty P Parkkonen ML Kantanen J Hakulinen, Adv Virus Res 1993 42 149 186 7679241
46. Prediction of the secondary structure of proteins from their amino acid sequence. PY Chou GD Fasman, Adv Enzymol Relat Areas Mol Biol 1978 47 45 148 364941
47. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. EA Emini JV Hughes DS Perlow J Boger, J Virol 1985 55 836 839 2991600
48. Prediction of chain flexibility in proteins - A tool for the selection of peptide antigens. PA Karplus GE Schulz, Naturwissenschafren 1985 72 212 213
49. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. JM Parker D Guo RS Hodges, Biochemistry 1986 25 5425 5432 2430611
50. Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis. JC Goodall H Beacock-Sharp KH Deane JS Gaston, Clin Exp Immunol 2001 126 488 493 11737067
51. A spontaneous direct repeat deletion in the pGEX fusion vector decreases the expression level of recombinant proteins in Escherichia coli. I Borgi A Gargouri, Protein Expr Purif 2008 60 15 19 18434194
52. A simple procedure for expression and purification of selected non-structural (alpha and beta) herpes simplex virus 1 (HSV-1) proteins. J Kosovsky V Durmanova M Kudelova I Rezuchova L Tkacikova J Rajcani, J Virol Methods 2001 92 121 129 11226559
53. Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients. R Cressey S Pimpa B Chewaskulyong N Lertprasertsuke S Saeteng C Tayapiwatana W Kasinrerk, BMC Biotechnol 2008 8 16 18284706
54. PinPoint™ Xa Protein Purification System, Instructions for the use of product V2020. Technical Manual Promega, Part TM028 Madison, WI 1996
55. Problems with biotin-labelled virions as probes in poliovirus-specific mu-capture-IgM assays. S Valtanen M Roivainen T Hovi, J Clin Virol 1999 14 17 23 10548126
56. Enzyme-linked immunosorbent assays using the recombinant dense granule antigens GRA6 and GRA1 of Toxoplasma gondii for detection of immunoglobulin G antibodies. L Lecordier MP Fourmaux C Mercier E Dehecq E Masy MF Cesbron-Delauw, Clin Diagn Lab Immunol 2000 7 607 611 10882660
57. Comparison of the immunoglobulin-G-specific seroreactivity of different recombinant antigens of the human herpesvirus 8. D Lang W Hinderer M Rothe HH Sonneborn F Neipel M Raab H Rabenau B Masquelier H Fleury, Virology 1999 260 47 54 10405355
58. Recombinant antigens for immunodiagnosis of cystic echinococcosis. J Li WB Zhang DP McManus, Biol Proced Online 2004 6 67 77 15188015
59. Immunogenicity of Plasmodium vivax merozoite surface protein-9 recombinant proteins expressed in E. coli. J Oliveira-Ferreira E Vargas-Serrato JW Barnwell A Moreno MR Galinski, Vaccine 2004 22 2023 2030 15121316
60. Cloning, expression and immunological reactivity of two mammalian cell entry proteins encoded by the mce1 operon of Mycobacterium tuberculosis. S Ahmad PK Akbar HG Wiker M Harboe AS Mustafa, Scand J Immunol 1999 50 510 518 10564554
61. Characterization of the humoral immune response to Chlamydia outer membrane protein 2 in chlamydial infection. I Portig JC Goodall RL Bailey JS Gaston, Clin Diagn Lab Immunol 2003 10 103 107 12522047
62. Persistence of chlamydial antibodies after pelvic inflammatory disease. M Puolakkainen E Vesterinen E Purola P Saikku J Paavonen, J Clin Microbiol 1986 23 924 928 3711278
63. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. K Persson, Best Pract Res Clin Obstet Gynaecol 2002 16 801 814 12473283
64. Acute primary Chlamydia trachomatis infection in male adolescents after their first sexual contact. I Srugo R Gershtein S Madjar I Elias J Tal O Nativ, Arch Pediatr Adolesc Med 2000 154 169 172 10665604
65. Kinetic study of antibodies (IgG, IgA) to Chlamydia trachomatis : importance of IgA antibody in screening test for C. trachomatis infection by peptide-based enzyme immunosorbent assay. T Komoda, Jpn J Infect Dis 2007 60 347 351 18032832